CIRRHOSIS, LIVER

This study is testing whether a 6-month coaching program delivered via smartphone can help people with early liver disease. Participants are randomly assigned to either start the program immediately or wait 6 months. The program uses texts and support to help people improve their…

This study aims to determine if antibiotics are necessary during endoscopic procedures to prevent re-bleeding in patients with liver cirrhosis who have previously experienced variceal bleeding. Researchers are comparing outcomes between patients who receive preventive antibiotics…

This study is testing whether a special exercise program before a liver transplant, and continued training after surgery, helps people recover better. It will involve 60 adults waiting for a transplant and measure how the program affects hospital stays, complications, strength, a…

This study aimed to see if the antibiotic rifaximin could improve subtle thinking problems (covert hepatic encephalopathy) in people with liver cirrhosis, especially when those problems are linked to an overgrowth of gut bacteria. The plan was to treat about 40 patients for eight…

This study is testing if a drug called angiotensin 2, given during liver transplant surgery, can prevent kidney injury afterward. It will involve about 30 adults with severe liver disease who are receiving a transplant. Half will get the study drug along with standard medications…

This study aims to understand the financial burden and stress experienced by patients with liver cirrhosis and their family caregivers. It follows 52 participants and their caregivers for 72 weeks, tracking out-of-pocket medical costs, lost work productivity, and overall financia…

This study aims to gather real-world information on a common procedure for liver cirrhosis called TIPS. It will follow 852 patients for up to 5 years after they get the shunt as part of their normal care. The goal is to create a database to answer key questions about how to best …

This study aims to better understand which adults with liver cirrhosis are most at risk for serious health complications. It will follow over 1,200 participants with liver scarring, checking in with them every six months to collect health data, images, and samples. The goal is to…

This study aims to find out how common fatty liver disease and serious liver scarring are in adults with type 1 diabetes. Researchers will screen over 500 patients using a quick, non-invasive scan and blood tests. The goal is to identify patients at high risk who may need to see …